KR840000396B1 - 테트라하이드로이소퀴놀린 화합물의 제조방법 - Google Patents

테트라하이드로이소퀴놀린 화합물의 제조방법 Download PDF

Info

Publication number
KR840000396B1
KR840000396B1 KR1019800002551A KR800002551A KR840000396B1 KR 840000396 B1 KR840000396 B1 KR 840000396B1 KR 1019800002551 A KR1019800002551 A KR 1019800002551A KR 800002551 A KR800002551 A KR 800002551A KR 840000396 B1 KR840000396 B1 KR 840000396B1
Authority
KR
South Korea
Prior art keywords
tetrahydroisoquinoline
mixture
compounds
epinephrine
methyltransferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019800002551A
Other languages
English (en)
Korean (ko)
Other versions
KR830002791A (ko
Inventor
에드워드 본다니엘 윌리암
로버트 지라드 제랄드
Original Assignee
스미스 클라인 백크만 코노포레이션
리챠드 도미닉 포기오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스미스 클라인 백크만 코노포레이션, 리챠드 도미닉 포기오 filed Critical 스미스 클라인 백크만 코노포레이션
Publication of KR830002791A publication Critical patent/KR830002791A/ko
Application granted granted Critical
Publication of KR840000396B1 publication Critical patent/KR840000396B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
KR1019800002551A 1979-07-02 1980-06-28 테트라하이드로이소퀴놀린 화합물의 제조방법 Expired KR840000396B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5434379A 1979-07-02 1979-07-02
US54343 1979-07-02
US54345 2001-11-13

Publications (2)

Publication Number Publication Date
KR830002791A KR830002791A (ko) 1983-05-30
KR840000396B1 true KR840000396B1 (ko) 1984-03-30

Family

ID=21990408

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800002551A Expired KR840000396B1 (ko) 1979-07-02 1980-06-28 테트라하이드로이소퀴놀린 화합물의 제조방법

Country Status (30)

Country Link
EP (1) EP0023761B1 (enExample)
JP (1) JPS5610192A (enExample)
KR (1) KR840000396B1 (enExample)
AR (1) AR225925A1 (enExample)
AT (1) ATE6515T1 (enExample)
AU (1) AU531641B2 (enExample)
BG (1) BG51250A3 (enExample)
CA (1) CA1129415A (enExample)
CS (1) CS215064B2 (enExample)
DD (1) DD151750A5 (enExample)
DE (1) DE3066826D1 (enExample)
DK (1) DK151029C (enExample)
ES (1) ES492971A0 (enExample)
FI (1) FI67221C (enExample)
GR (1) GR69206B (enExample)
HU (1) HU179382B (enExample)
IE (1) IE50290B1 (enExample)
IL (1) IL60426A (enExample)
IN (1) IN160542B (enExample)
MX (1) MX6317E (enExample)
NO (1) NO801951L (enExample)
NZ (1) NZ194156A (enExample)
PH (1) PH17042A (enExample)
PL (2) PL230619A1 (enExample)
PT (1) PT71458A (enExample)
RO (1) RO79707A (enExample)
SU (1) SU1072809A3 (enExample)
YU (1) YU171180A (enExample)
ZA (1) ZA802987B (enExample)
ZW (1) ZW14680A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352809A (en) * 1981-09-04 1982-10-05 Smithkline Corporation Method of producing alpha2 antagonism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3939164A (en) * 1974-02-08 1976-02-17 Smithkline Corporation 7 AND 8-Halo substituted 1,2,3,4-tetrahydroisoquinoline compounds
US3988339A (en) * 1974-02-08 1976-10-26 Smithkline Corporation Pharmaceutical compositions and methods of inhibiting phenylethanolamine N-methyltransferase

Also Published As

Publication number Publication date
YU171180A (en) 1983-09-30
DE3066826D1 (en) 1984-04-12
ES8105736A1 (es) 1981-06-01
PH17042A (en) 1984-05-17
ES492971A0 (es) 1981-06-01
FI67221C (fi) 1985-02-11
CA1129415A (en) 1982-08-10
AR225925A1 (es) 1982-05-14
EP0023761A1 (en) 1981-02-11
HU179382B (en) 1982-10-28
NZ194156A (en) 1983-03-15
KR830002791A (ko) 1983-05-30
FI802112A7 (fi) 1981-01-03
DK151029B (da) 1987-10-12
GR69206B (enExample) 1982-05-07
BG51250A3 (bg) 1993-03-15
IE50290B1 (en) 1986-03-19
IL60426A0 (en) 1980-09-16
FI67221B (fi) 1984-10-31
PT71458A (en) 1980-07-01
MX6317E (es) 1985-04-01
AU531641B2 (en) 1983-09-01
IN160542B (enExample) 1987-07-18
EP0023761B1 (en) 1984-03-07
AU5967780A (en) 1981-01-15
PL127098B1 (en) 1983-09-30
ATE6515T1 (de) 1984-03-15
RO79707A (ro) 1982-08-17
ZA802987B (en) 1981-05-27
IE801352L (en) 1981-01-02
CS215064B2 (en) 1982-07-30
IL60426A (en) 1984-03-30
DK151029C (da) 1988-03-07
DD151750A5 (de) 1981-11-04
SU1072809A3 (ru) 1984-02-07
DK274280A (da) 1981-01-03
PL230619A1 (enExample) 1981-12-11
PL225377A1 (enExample) 1981-08-21
NO801951L (no) 1981-01-05
ZW14680A1 (en) 1980-09-24
JPS5610192A (en) 1981-02-02

Similar Documents

Publication Publication Date Title
EP0032128A1 (en) Thiazolidine derivatives and their production and use
KR850001884B1 (ko) 수용성 벤조티아진 디옥시드염류의 제조방법
JPS6330309B2 (enExample)
JPS6229566A (ja) 新規グアニジノメチル安息香酸誘導体
US4128666A (en) 4 AND 5-Halo substituted 2-indanamine compounds
US4939164A (en) Strontium salt
KR840000396B1 (ko) 테트라하이드로이소퀴놀린 화합물의 제조방법
EP0214740A2 (en) Dopamine-beta-hydroxylase inhibitors
US4361700A (en) Pyridopyrimidinone derivatives
CH630638A5 (fr) Nouveaux derives de la pyrido-(2,2-b)benzothiazepine-(1,5) substitues en position 5.
US4927821A (en) Enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, and their use
EP0079639B1 (en) A new anti-inflammatory drug
FR2460934A1 (fr) Derives d'isoquinoleine contenant du soufre, procedes pour leur preparation et compositions pharmaceutiques les contenant
US4258049A (en) Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines
CS228929B2 (cs) Způsob výroby ve vodě rozpustných solí N-(2-pyridyl)-2-methyl-4-hydroxy-2H-l,2-benzothiazin-3-karboxamid-l,l-dioxidu
US4297487A (en) Phosphonium salts
US4242346A (en) Bis-2N-alkylene tetrahydroisoquinoline compounds
US4272531A (en) 3,3'-Bis-methylene-1,3-benzo-thiazine compounds
RU2068415C1 (ru) 5,7-диокси-2-метил-8-/4-(3-окси-1-(1-пропил)пиперидинил/-4н-1-бензопиран-4-он или его стереоизомеры или фармакологически приемлемые кислотно-аддитивные соли и способ их получения
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
CH634075A5 (en) Process for the preparation of hydrated imidazothiazole and thiazolopyrimidine derivatives having an anti-inflammatory activity
JPS6117832B2 (enExample)
HU208424B (en) Process for producing new cyclicantranyl-acetic acid derivatives salts with acids and bases and pharmaceutical compositions containing them as active components
SU1739851A3 (ru) Способ получени производных тиено(3 @ ,4 @ :4,5)имидазо(2,1- @ )тиазола
KR800001630B1 (ko) 벤질아민의 제조방법

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19880330

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19880330